METHODS AND SYSTEMS FOR REDUCING ULTRASOUND ARTIFACTS
20170105792 ยท 2017-04-20
Inventors
Cpc classification
A61B2017/22007
HUMAN NECESSITIES
A61B2018/00583
HUMAN NECESSITIES
A61B2018/1475
HUMAN NECESSITIES
A61B2018/00982
HUMAN NECESSITIES
International classification
Abstract
Methods of and systems for monitoringvia an ultrasonic imaging devicethe delivery of radio-frequency energy are described herein. The articles may be ultrasonically echogenic to assist with guidance.
Claims
1. A method of using ultrasound imaging to guide the use of an ablation device, the method comprising providing an ultrasound imaging device; providing an ablation device configured to deliver radio-frequency (RF) energy to a target tissue, the device comprising: a shaft having a distal end, a proximal end, one or more delivery lumens, and one or more aspiration lumens; a fluid control apparatus fluidly coupled to the one or more delivery lumens and the one or more aspiration lumens; an RF probe extending through the shaft; an RF energy source operatively coupled to the probe to deliver RF energy; and a system controller configured to coordinate the operation of the fluid control apparatus and the RF energy source so as to deliver and remove fluid to reduce ultrasound imaging artifacts to allow for continued monitoring of the ablation procedure; positioning the distal end of the shaft proximate an ablation site using the ultrasound imaging device; delivering fluid to the ablation site through the one or more delivery lumens; removing at least a portion of the fluid from the ablation site through the one or more aspiration lumens; and selectively delivering RF energy to the ablation site to remove tissue at the ablation site; and continuing to monitor the ablation procedure using the ultrasound imaging device.
2. The method of claim 1, wherein the fluid is delivered to the ablation site at the same time as or for a selected period of time before RF energy is delivered to ablation site, and wherein the fluid is delivered to the ablation site for a selected period of time after the delivery of RF energy to the ablation site is terminated.
3. The method of claim 1, wherein the RF probe is a coblation probe.
4. The method of claim 1, wherein the ultrasound imaging artifacts comprise gas bubbles formed by the delivery of the RF energy to the ablation site.
5. The method of claim 1, wherein reducing ultrasound imaging artifacts comprises reducing the formation of ultrasound imaging artifacts.
6. The method of claim 1, wherein the fluid control apparatus is further configured to monitor and control the temperature of the fluid.
7. The method of claim 1, wherein the fluid control apparatus is further configured to monitor the temperature of the fluid.
8. The method of claim 1, wherein the RF probe is held at a fixed position relative to the shaft.
9. The method of claim 1, wherein the RF probe is movable within the shaft such that the RF probe comprises a retracted position in which a tip of the RF probe is proximate the distal end of the shaft and an extended position in which the tip of the RF probe is spaced from the distal end of the shaft.
10. The method according to claim 1, further comprising delivering the fluid to the ablation site at a temperature below 20 C.
11. A method of monitoring an ablation procedure using an ultrasound imaging device, the method comprising: positioning the ultrasound imaging device near a portion of a patient's body that contains an ablation site; providing an ablation device configured to deliver radio-frequency (RF) energy to the ablation site, the device comprising: a shaft having a distal end, a proximal end, one or more delivery lumens, and one or more aspiration lumens; a fluid control apparatus fluidly coupled to the one or more delivery lumens and the one or more aspiration lumens; an RF probe extending through the shaft; an RF energy source operatively coupled to the probe to deliver RF energy; and a system controller configured to coordinate the operation of the fluid control apparatus and the RF energy source so as to deliver and remove fluid to reduce ultrasound imaging artifacts to allow for continued monitoring of the ablation procedure; positioning the distal end of the shaft proximate an ablation site using the ultrasound imaging device; delivering fluid to the ablation site through the one or more delivery lumens; removing at least a portion of the fluid from the ablation site through the one or more aspiration lumens; and selectively delivering RF energy to the ablation site to remove tissue at the ablation site; and monitoring the ablation procedure using the ultrasound imaging device.
12. The method of claim 11, wherein the fluid is delivered to the ablation site at the same time as or for a selected period of time before RF energy is delivered to ablation site, and wherein the fluid is delivered to the ablation site for a selected period of time after the delivery of RF energy to the ablation site is terminated.
13. The method of claim 11, wherein the RF probe is a coblation probe.
14. The method of claim 13, wherein the ultrasound imaging artifacts comprise gas bubbles formed by the delivery of the RF energy to the ablation site.
15. The method of claim 14, wherein reducing ultrasound imaging artifacts comprises reducing the formation of ultrasound imaging artifacts.
16. The method of claim 11, wherein the fluid control apparatus is further configured to monitor and control the temperature of the fluid.
17. The method of claim 16, wherein the temperature of the fluid is kept below about 20 C.
18. The method of claim 11, wherein the RF probe is held at a fixed position relative to the shaft.
19. The method of claim 11, wherein the RF probe is movable within the shaft such that the RF probe comprises a retracted position in which a tip of the RF probe is proximate the distal end of the shaft and an extended position in which the tip of the RF probe is spaced from the distal end of the shaft.
20. The method according to claim 11, wherein the fluid delivered via the delivery lumens has a temperature below 20 C.
Description
BRIEF DESCRIPTION OF DRAWINGS
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037] Like reference symbols in the various drawings indicate like elements.
DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
[0038] In the following detailed description of illustrative embodiments, reference is made to the accompanying figures of the drawing which form a part hereof, and in which are shown, by way of illustration, specific embodiments of this disclosure. It is to be understood that other embodiments may be utilized and structural changes may be made without departing from the scope of the present disclosure.
[0039]
[0040] The channel 114 in the shaft 110, within which the coblation probe 111 is located, may preferably extend to the distal end of the shaft 110 as depicted in
[0041]
[0042] The channel 214 in the shaft 210, from which the coblation probe 211 extends, may preferably terminate short of the distal end of the shaft 210 as depicted in
[0043] Although the coblation probes of coblation systems described herein may have stationary positions relative to the shafts in which they are located such that the coblation probe is held at a fixed position relative to the shaft, in some embodiments, the coblation probe may be capable of moving relative to the shaft.
[0044] Withdrawal of the probe 311 from the extended position towards the proximal end of the shaft 310 may preferably create a void that will be filled by the fluid delivered through the delivery lumen. This movement and subsequent filling may enhance aspiration through lumen 313 of the fluid delivered to the ablation site through lumen 312.
[0045]
[0046] The fluid control apparatus 420 may optionally include a temperature control mechanism 422 capable of controlling the temperature of the fluid delivered to the coblation device 410 from the fluid control apparatus 420. The temperature control mechanism may be in the form of a refrigeration unit or a thermal sink capable of reducing the temperature of the fluid delivered to the coblation device to a temperature below 20 degrees Celsius (or any other selected temperature).
[0047] In addition to the coblation systems described herein, the present disclosure also encompasses tissue dilation apparatus that may potentially be used to provide access for a coblation probe and/or may be used alone to provide tissue dilation.
[0048] In one exemplary embodiment, the tissue dilation apparatus may include a shaft with a pointed or tapered tip at one end a fluid connection fitting at the opposite end. An expansion device (in the form of, e.g., an inflatable balloon) may preferably be attached to the shaft proximate the distal end of the shaft.
[0049] The shaft may be hollow such that fluids can be delivered through the shaft as discussed herein and/or the shaft may be sized to operate as a cannula with one or more lumens that can be used to deliver one or more working instruments, fluids, etc. to targeted body tissue. For example, the shaft may be used to deliver a coblation probe.
[0050] The shaft may be of any desired thickness, although it may be preferred that the shaft be in the range of 10 gauge to 30 gauge. It may be preferred that the shaft be substantially rigid such that it does not deflect significantly under normal use (e.g., the shaft may be made of metals or other materials capable of providing the desired rigidity).
[0051] Although stainless steel may preferably be used to construct the shaft, many other materials could be substituted. In general, however, it may be preferred that at least some material used in the shaft be ultrasonically echogenic where echogenic materials are materials may be visualized or otherwise guided using ultrasonic energy. In some instances, the shaft may be, e.g., coated or otherwise treated (e.g., etched, etc.) to improve its ability to be ultrasonically detected.
[0052] The shaft may, in some embodiments, have a solid tip (as opposed to the open tips of, e.g., Quincke-type needles) and the lumen defined in the hollow shaft may terminate at one or more openings through the sidewall of the shaft. Those openings may preferably be in fluid communication with the interior of an inflatable balloon attached to the shaft. The openings may, in some instances, improve the echogenicity to improve conspicuity of the apparatus when using ultrasonic energy. The use of multiple openings into the interior of the expansion device may be useful for more accurately determining the location of the expansion device.
[0053] The proximal end of the shaft may include a fluid connection such as, e.g., a Luer lock fitting, etc. to permit fluid-tight attachment to a source of fluid to be delivered through the lumen of the shaft. In use, the fitting may be attached to a syringe or other fluid delivery device. In embodiments to be used an access cannula to deliver one or more working instruments to targeted body tissue, the proximal end of the shaft may include one or more connectors that connect to, e.g., a working instrument, coblation probe, etc. as described herein.
[0054] The length of the shaft may vary depending on the needs of the user, although in some embodiments the length of the shaft may be, e.g., 200 millimeters (mm) or less (where the shaft length is measured from the proximal end to the distal end). In some embodiments, the length may preferably be 100 mm or less. It may be preferred that the expansion device (e.g., inflatable balloon) occupy a distance of about 10% or more of the length of the shaft, hi other embodiments, the expansion device may occupy 25% or more of the length of the shaft. In terms of actual dimensions, the expansion device may have a length of, e.g., 5 mm or more, 10 mm or more, 20 mm or more, or even 50 mm or more.
[0055] The expansion device located near the distal end of the apparatus may be in the form of one or more inflatable balloons. Materials used for the balloons may preferably be flexible such that the expansion device is capable of taking a collapsed configuration for delivery to a desired location where the expansion device can be expended to an expanded configuration. Suitable materials may include, e.g., polyethylenes, etc. It may be preferred that the balloon material allow for the transmission of ultrasonic energy such that the portion of the shaft located within the balloon can be detected using ultrasonic energy.
[0056] The expansion device may preferably have a profile or shape that is relatively small, e.g., similar to the dimensions of the shaft on or to which the expansion device is mounted. The expansion device may take on a variety of shapes when in the expanded configuration. Examples of some potential shapes in the expanded configuration may include, but are not limited to narrow oblong shapes, near spherical shapes, spherical shapes, two or more lobes, etc.
[0057] When deploying the tissue dilation apparatus, ultrasound guidance may be used to guide the shaft to a desired internal body location with the expansion device is preferably in the collapsed configuration. This process may be similar to that used in an ultrasound-guided injection and/or other procedures as described herein. The shaft may, for example, be passed through the area in which the stenosis is located until the expansion device (e.g., balloon) is positioned in the region to be dilated.
[0058] With the expansion device in position, the expansion device is then expanded from the collapsed configuration to the expanded configuration. When the expansion device is in the form of an inflatable balloon, the expansion may preferably be caused by passing a fluid such as, e.g., distilled sterile water, degassed sterile ultrasound gel, etc. It may be preferred that the fluid used be non-echogenic such that ultrasonic visualization of the expansion site is not significantly impaired during the expansion process. It may further preferred that the distention caused by the expansion device be monitored (e.g., visualized) using concomitant ultrasound imaging or any other suitable visualization technology. The expansion device may be maintained in its expanded configuration for any selected period of time, e.g., from a few seconds to minutes. Further, the expansion device may be expanded and collapsed only once or it may be repeatedly expanded and collapsed as need to provide the desired tissue distention. If the expansion device is repeatedly expanded and collapsed, the amount of expansion may be varied, e.g., the size of the expansion device may be progressively increased with each expansion, etc.
[0059]
[0060] The tissue dilation apparatus 510 of
[0061] Although both lobes of the expansion device 502 are expanded (as depicted in
[0062] Although the expansion device 502 may be filled by delivering a fluid through the main channel of the shaft 504 (where, e.g., the distal end of the shaft 504 is sealed), an auxiliary channel located within the shaft 504 (if hollow) or positioned external to the shaft 504 (whether the shaft 504 is solid or hollow) may be used to deliver fluids to and/or remove fluids from the expansion device 502. If the shaft 504 is hollow and an auxiliary channel is used to dilate the expansion device 502, the hollow shaft 504 can potentially be used to deliver other fluids (e.g., therapeutic substances, etc.) or other devices such as the coblation probes described herein to an internal body location.
[0063]
[0064] With the expansion device 602 in a selected position, the expansion device 602 can be dilated to the expanded configuration (as depicted in
[0065] In some instances, the primary shaft 604 may be flexible, with the primary shaft 604 and collapsed expansion device 602 being introduced to a selected body site while a support structure (e.g., a solid or hollow needle, etc.) is located within the main channel 605 (to give the primary shaft 604 sufficient stiffness to facilitate advancement to a selected location). After the expansion device 602 is in the selected position (and possibly dilated), the support structure may be removed from the main channel 605, with the primary shaft 604 and its main channel 605 serving as a defined path through which other devices, fluids, etc. can be delivered. For example, the main channel 605 may be sized to allow a coblation device (such as, e.g., the coblation devices described herein) to be advanced through the main channel 605.
[0066] Although the primary shaft 604 may itself be echogenic, in some embodiments, the echogenicity may be provided by the support structure (if used) while the primary shaft 604 and the expansion device 602 are substantially transparent to the ultrasonic energy used for guiding the tissue dilation apparatus. In such an embodiment, the echogenic support structure may be removed to allow unobstructed ultrasonic visualization of the body site at which the expansion device 602 is deployed (in those embodiments in which the primary shaft 604 and the expansion device 602 are non-echogenic). hi still another variation, the auxiliary shaft 606 may be echogenic while the primary shaft 606 is not, such that ultrasonic guidance can be used to position the expansion device 602, with the primary shaft 604 obscuring less of the field of interest.
[0067] Also, in some embodiments, a pressure sensor may be provided to monitor fluid pressure within the expansion device.
[0068] The systems, apparatus and methods described herein may advantageously be used in connection with the systems, devices and methods described in, e.g., PCT Patent Application No. PCT/US09/34659, titled SYSTEMS, DEVICES AND METHODS FOR ACCESSING BODY TISSUE, filed on even date herewith and/or U.S. Provisional Patent Application Ser. No. 61/030,009, titled ACCESSING AND TREATING BODY TISSUE, filed on February 20, 2008.
[0069] The words preferred and preferably as used herein refer to embodiments that may afford certain benefits, under certain circumstances. However, other embodiments may also be preferred, under the same or other circumstances. Furthermore, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful, and is not intended to exclude other embodiments from the scope of the invention.
[0070] As used herein, a, an, the, at least one, and one or more are used interchangeably. Thus, for example, a coblation probe may refer to one, two or more coblation probes.
[0071] The term and/or means one or all of the listed elements or a combination of any two or more of the listed elements.
[0072] The complete disclosure of the patents, patent documents, and publications identified herein are incorporated by reference in their entirety as if each were individually incorporated.
[0073] Illustrative embodiments are discussed and reference has been made to possible variations within the scope of this disclosure. These and other variations and modifications will be apparent to those skilled in the art without departing from the scope of the invention, and it should be understood that this invention is not limited to the illustrative embodiments set forth herein. Accordingly, the invention is to be limited only by the claims provided below and equivalents thereof.